These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17974581)

  • 21. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk estimates for deterministic health effects of inhaled weapons grade plutonium.
    Scott BR; Peterson VL
    Health Phys; 2003 Sep; 85(3):280-93. PubMed ID: 12938719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two case studies of highly insoluble plutonium inhalation with implications for bioassay.
    Carbaugh EH; La Bone TR
    Radiat Prot Dosimetry; 2003; 105(1-4):133-8. PubMed ID: 14526943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worldwide bioassay data resources for plutonium/americium internal dosimetry studies.
    Miller G; Riddell AE; Filipy R; Bertelli L; Little T; Guilmette R
    Radiat Prot Dosimetry; 2007; 125(1-4):531-7. PubMed ID: 17337740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-year follow-up of a Pu/Am inhalation case.
    Wernli C; Eikenberg J
    Radiat Prot Dosimetry; 2007; 125(1-4):506-12. PubMed ID: 17298952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early faecal excretion of inhaled plutonium.
    Kurihara O; Momose T; Tasaki T; Hayashi N; Shinohara K
    Radiat Prot Dosimetry; 2002; 102(2):137-44. PubMed ID: 12408490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful DTPA therapy in the case of 239Pu penetration via injured skin exposed to nitric acid.
    Khokhryakov VF; Belyaev AP; Kudryavtseva TI; Schadilov AE; Moroz GS; Shalaginov VA
    Radiat Prot Dosimetry; 2003; 105(1-4):499-502. PubMed ID: 14527017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plutonium ( 239 Pu) toxicity diagnosis and therapy.
    Norwood WD
    J Occup Med; 1972 Jan; 14(1):37-44. PubMed ID: 5058618
    [No Abstract]   [Full Text] [Related]  

  • 30. Implications of Cloth COVID Masks for Size Distribution of Inhaled Plutonium, Respiratory Deposition, and Fecal Bioassay Monitoring.
    Klumpp J; Poudel D
    Health Phys; 2021 Jul; 121(1):73-76. PubMed ID: 34002728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of monitoring data for 239Pu accidentally injected via wound site based on the proposed NCRP wound model.
    Ishigure N
    Radiat Prot Dosimetry; 2007; 127(1-4):108-13. PubMed ID: 17561522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of the plutonium lung clearance model for exposure estimation of the Mayak production association, nuclear plant workers.
    Khokhryakov VF; Suslova KG; Vostrotin VV; Romanov SA; Menshikh ZS; Kudryavtseva TI; Filipy RE; Miller SC; Krahenbuhl MP
    Health Phys; 2002 Apr; 82(4):425-31. PubMed ID: 11906131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of accidental personnel exposure to plutonium-238: whole body counting and bioassay results.
    Anderson HF; Sheehan WE; Mann JR; Bistline RW
    Health Phys; 1970 Jun; 18(6):631-9. PubMed ID: 4998034
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
    Dumit S; Miller G; Klumpp JA; Poudel D; Bertelli L; Waters TL
    Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of state of health on organ distribution and excretion of systemic plutonium in the Mayak workers.
    Suslova KG; Khokhryakov VF; Tokarskaya ZB; Nifatov AP; Sokolova AB; Kudryavtzeva TI; Miller SC; Krahenbuhl MP
    Radiat Prot Dosimetry; 2003; 105(1-4):229-33. PubMed ID: 14526961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of track detector for the measurement of urine plutonium].
    Bataller G
    Ann Pharm Fr; 1994; 52(6):277-93. PubMed ID: 7864528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual monitoring for internal contamination with plutonium compounds at JAEA-NCL.
    Kurihara O; Kanai K
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):144-7. PubMed ID: 21493601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A respiratory model for uranium aluminide based on occupational data.
    Leggett RW; Eckerman KF; Boice JD
    J Radiol Prot; 2005 Dec; 25(4):405-16. PubMed ID: 16340069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.